Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. ...
Streetwise Reports | April 2, 2020 |

Quantum Economics, Negative Interest Rates and Financially Transmitted Diseases

This week the US Federal Reserve announced an emergency rate cut of 0.5% (50bps). It is part of a coordinated effort by central bankers around the world to keep the decade long bull market going a few days longer. Ultra low interest rates and ever depreciating currencie...
Marin Katusa | March 6, 2020 |

Vir Partners with Samsung Biologics on Large-Scale Manufacture of COVID-19 Antibody Treatment

Vir Biotechnology reported it has entered into an agreement with Samsung Biologics valued at $362 million for large-scale manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Though U.S. markets are closed for the Good Friday holiday, Samsung Biologics shar...
Streetwise Reports | April 13, 2020 |

An 'Electrical Storm' of Catalysts Converge to Jump Start Sales of Eguana's Solar-Power ...

An 'Electrical Storm' of Catalysts Converge to Jump Start Sales of Eguana's Solar-Power Storage Solutions The small-cap energy storage firm just signed a global production agreement with industry heavyweight Jabil. The Punch: Eguana Technologies Inc. (EGT:...
Streetwise Reports | September 11, 2019 |

Buzz on the Bullboards: Investors Talk Cannabis on “10/17”

In the United States, they have “420”. This pop culture reference was a numerical label for 4:20 pm – a time when (according to this urban legend) a group of California high school students would meet to smoke cannabis. But this is also a symbol of the e...
Stockhouse Editorial | October 18, 2018 |

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

Avadel Pharmaceuticals' shares are trading 30% higher today on news that the FDA agreed to reduce the sample size required for its Phase 3 REST-ON study, accelerating its completion by year-end 2019. Dublin, Ireland-based Avadel Pharmaceuticals Plc (AVDL:NASDAQ) , wh...
Streetwise Reports | September 24, 2019 |

Part II – We Are Concerned About The Real Estate Market

In this second part of our research into the potential collateral damage, the Covid-19 global virus event may cause in the housing and commercial real estate markets, we want to start by sharing some information that severe cracks are already starting to appear in the entire...
Chris Vermeulen | March 23, 2020 |

Technical Analyst: Silver Looks Bearish Short to Medium Term

Technical analyst Clive Maund charts silver and explains why he is bearish in the short to medium term. Whichever way you cut it, silver's chart looks bearish for the short to medium term, but against this we must set its rapidly improving COT structure and ...
Streetwise Reports | March 31, 2020 |

A Unique Play in the Hungry US Hemp Market

(Image via Cascadia Extracts.) Utilizing high capacity CO 2 extraction equipment to tap into the extremely underserviced hemp market, Cascadia Extracts ( P. CASCADIA , Forum ) uses unique technology to take advantage of the significant benefits associated w...
Stockhouse Editorial | September 23, 2020 |

Gilead Drug May Cure COVID-19 But Won’t Save the Markets

Big news out today on CNBC about Gilead drug cured all 125 people from serious COVID-19 conditions within 5 days, This is amazing to hear, stocks are popping today up 3-5% which is to be expected for this type of news but the damage to the financial markets has already been ...
Chris Vermeulen | April 17, 2020 |
1 2